ArticleBrain and behavior2025
Pain Coping in Patients With Chronic Migraine and Medication Overuse Headache.
Article in Brain and behavior, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- An exploration of possible future non-pharmacological multidisciplinary treatments to potentiate withdrawal strategy and recovery from medication overuse headache (MOH): a narrative review.Journal of oral & facial pain and headache · 2026Review
- Prevalence, medication use, and health care utilization in pediatric primary headache: a school-based cross-sectional study.The journal of headache and pain · 2026Article
- Pain Coping in Patients With Chronic Migraine and Medication Overuse Headache.Brain and behavior · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundChronic migraine (CM) is a leading cause of disability and often linked to medication overuse headache (MOH). Psychological factors, such as pain coping, may contribute to chronification and medication overuse. While behavioral therapy can help, identifying patients who will benefit remains challenging. This study compared pain coping in individuals with CM and MOH to those with episodic migraine (EM) and controls without headache. It also assessed whether baseline pain coping in CM patients could predict withdrawal treatment success.
methodsIn patients that received behavioral therapy as part of the Chronification and Reversibility of Migraine clinical trial, patients with CM and MOH were assessed at baseline and after treatment on pain acceptance with the Acceptance and Action Questionnaire II for Pain (AAQ-II-P), and with the Pain-catastrophizing scale (PCS) and Headache Specific Locus of Control (HSLC) questionnaires. The non-headache groups were assessed once. In total, 65 CM, 34 EM, and 49 non-headache controls were included.
resultsPatients with CM experienced less pain acceptance compared with EM patients and healthy controls with AAQ-II-P (adjusted mean difference [AMD]: 10.0 [95% CI: 3.7-16.2], p < 0.001 and AMD: 13.9 [95% CI: 7.8-20.1], p < 0.001, respectively) and had higher PCS (AMD: 12.1 [95% CI: 5.2-19.0], p < 0.001, AMD: 17.3 [95% CI: 10.5-24.0], p < 0.001, respectively), but comparable PCS to patients with back pain or depression. Patients with CM were more likely to believe their headaches were due to coincidence compared to EM, HSLC-chance (AMD: 4.0 [95% CI: 0.3-7.7], p = 0.034). Importantly, higher PCS scores were associated with greater reduction in migraine days after treatment (OR: 1.06 [95% CI 1.01-1.11], p = 0.030).
conclusionsPatients with CM demonstrated poorer pain coping compared to those with EM and healthy controls. High catastrophizing in patients with CM predicts a better response to behavioral withdrawal treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.